A Clinical Trial of Cranberry and Elderberry Extracts (Berdi® Sachet) for Urinary Tract Infection in Pakistani Population

Main Article Content

Yasir Mehmood
Hafiz Umar
Humayun Riaz
Umar Farooq
Hammad Yousaf

Abstract

Lower urinary tract infection (UTI) is very common diseases. Recurrent UTI remain challenging to treat because the main treatment option is long-term antibiotic and this poses a risk for the emergence of bacterial resistance. Some options to avoid this risk are available, including the use of cranberry and elderberry products (herbal products extract). However, this can lead to the advent of bacterial resistance. The cross sectional study was designed to evaluated the efficacy of above products.  The study was conducted from 23 October 2019 to 28 October 2019 in Arif Memorial Teaching Hospital, Lahore, Pakistan. The subjects were outpatients aged 20 to 65 years. UTI symptoms were recorded in the daily diary before, during and after treatment and assessed by the Jackson score. Following approval by the Ethics Committee of Rashid Latif Pharmacy College, the questionnaire (ROUTE2-002) was compiled and information of UTI patients using cranberry and elderberry extracts (Berdi® Sachet) was collected. Compliance and tolerability were considerable obstacles in this study. A total of 67 patients were screened for participation; 12 were unwilling to participate and 55 were enrolled for clinical trial and all patients had urinary tract irritation. In this study 55 (100%) UTI patients were cured with cranberry and elderberry extracts (Berdi® Sachet). Further investigation is needed to confirm this effect and to evaluate the health benefits of cranberries and elderberry.

Keywords:
Urinary tract infection, cranberry, symptoms, cure.

Article Details

How to Cite
Mehmood, Y., Umar, H., Riaz, H., Farooq, U., & Yousaf, H. (2019). A Clinical Trial of Cranberry and Elderberry Extracts (Berdi® Sachet) for Urinary Tract Infection in Pakistani Population. Journal of Pharmaceutical Research International, 31(6), 1-6. https://doi.org/10.9734/jpri/2019/v31i630347
Section
Original Research Article

References

Foxman B. Epidemiology of urinary tract infections: Incidence, morbidity and economic costs. Disease-a-month. 2003; 49(2):53-70.

Russo TA, Johnson JR. Medical and economic impact of extraintestinal infections due to Escherichia coli: Focus on an increasingly important endemic problem. Microbes and Infection. 2003; 5(5):449-456.

Hooton TM. Recurrent urinary tract infection in women. International Journal of Antimicrobial Agents. 2001;17(4):259- 268.

Griebling TL. Urologic diseases in America project: trends in resource use for urinary tract infections in women. The Journal of Urology. 2005;173(4):1281-1287.

Sobel JD. Pathogenesis of urinary tract infection: Role of host defenses. Infectious disease clinics of North America. 1997; 11(3):531-549.

Svanborg C, Godaly G. Bacterial virulence in urinary tract infection. Infectious disease clinics of North America. 1997;11(3):513-529.

Guay DR. Contemporary management of uncomplicated urinary tract infections. Drugs. 2008;68(9):1169-1205.

Guay DR. Cranberry and urinary tract infections. Drugs. 2009;69(7):775-807.

Bruyere F. Use of cranberry in chronic urinary tract infections. Medecine et Maladies Infectieuses. 2006;36(7):358-363.

Kontiokari T, et al. Randomised trial of cranberry-lingonberry juice and Lactobacillus GG drink for the prevention of urinary tract infections in women. BMJ. 2001;322(7302):1571.

Jepson RG, Craig JC. A systematic review of the evidence for cranberries and blueberries in UTI prevention. Molecular Nutrition & Food Research. 2007;51(6): 738-745.

Cimolai N, Cimolai T. The cranberry and the urinary tract. European Journal of Clinical Microbiology & Infectious Diseases. 2007;26(11):767-776.

Lavigne JP. et al. In‐vitro and in‐vivo evidence of dose‐dependent decrease of uropathogenic Escherichia coli virulence after consumption of commercial Vaccinium macrocarpon (cranberry) capsules. Clinical Microbiology and Infection. 2008;14(4):350-355.